申请人:JIANGSU NHWALUOKANG PHARMACEUTICAL RESEARCH AND DEVELOPMENT CO., LTD.
公开号:US20180297958A1
公开(公告)日:2018-10-18
The present invention discloses an etomidate derivative of Formula 1, or a pharmaceutically acceptable salt, a polymorph, or a solvate thereof, a pharmaceutical composition and a kit comprising the same, as well as intermediates and methods for preparing the same, and use thereof. The etomidate derivative of the present invention not only has good anesthetic activity, rapid onset, and short duration of action, but also shows little inhibition to the secretion of corticosteroids in animals, and therefore has both favorable anesthetic effect and safety profiles.
本发明揭示了一种公式1的依托咪酯衍生物,或其药学上可接受的盐、多晶体或溶剂化物,以及包含它们的制药组合物和工具箱,还包括制备它们的中间体和方法,以及它们的用途。本发明的依托咪酯衍生物不仅具有良好的麻醉活性,快速起效和短暂作用时间,而且对动物的皮质类固醇分泌几乎没有抑制作用,因此具有良好的麻醉效果和安全性。